ACELYRIN INC
SLRN
ISIN US00445A1007 / Valor 126441937
ACELYRIN INC
UMushroom community rating:
About company
ACELYRIN, INC., based in Los Angeles, is a late-stage clinical biopharmaceutical company listed on the Nasdaq under the ticker symbol SLRN. The company is primarily engaged in the development and commercialization of transformative therapies. With a focus on accelerating the delivery of innovative treatments, ACELYRIN targets a range of diseases with significant unmet medical needs. While the specific therapeutic areas or products in development are not detailed, the company's commitment to advancing its pipeline suggests a strategic emphasis on bringing novel drugs through the clinical trial process to market. As a player in the biopharma sector, ACELYRIN appears to be positioning itself as a key contributor to medical advancements, leveraging scientific research to potentially improve patient outcomes in areas where current treatments may be lacking or insufficient.
Summarized from source with an LLMView SourceSector: HealthcareKey figures
Performance
Volatility
846 M
Market cap (USD)
236,701
Daily traded volume (Shares)
4.87 / 4.2
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
EQUITIES OF THE SAME SECTOR
